These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 38401325

  • 1. Use of non-invasive cardiac monitoring to guide discontinuation of postpartum magnesium sulfate in individuals with preeclampsia with severe features.
    Eid J, Ma'ayeh MM, Post S, Darin C, Rentsch S, Cackovic M, Rood KM, Costantine MM.
    Pregnancy Hypertens; 2024 Jun; 36():101112. PubMed ID: 38401325
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Duration of postpartum magnesium sulfate for seizure prophylaxis in women with preeclampsia: a systematic review and meta-analysis.
    Sullivan M, Cunningham K, Angras K, Mackeen AD.
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7188-7193. PubMed ID: 34187284
    [Abstract] [Full Text] [Related]

  • 4. Short-course postpartum (6-h) magnesium sulfate therapy in severe preeclampsia.
    Anjum S, Rajaram GP, Bano I.
    Arch Gynecol Obstet; 2016 May; 293(5):983-6. PubMed ID: 26498603
    [Abstract] [Full Text] [Related]

  • 5. Early magnesium discontinuation postpartum and eclampsia risk: A systematic review and meta-analysis.
    Quist-Nelson J, de Ruigh A, Lemoine ER, Pajkrt E, Mol B, Vigil-De Gracia P, Ludmir J, Askie L, Berghella V.
    Pregnancy Hypertens; 2024 Sep; 37():101141. PubMed ID: 39018830
    [Abstract] [Full Text] [Related]

  • 6. Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial.
    Pascoal ACF, Katz L, Pinto MH, Santos CA, Braga LCO, Maia SB, Amorim MMR.
    Medicine (Baltimore); 2019 Aug; 98(32):e16779. PubMed ID: 31393402
    [Abstract] [Full Text] [Related]

  • 7. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy.
    Fontenot MT, Lewis DF, Frederick JB, Wang Y, DeFranco EA, Groome LJ, Evans AT.
    Am J Obstet Gynecol; 2005 Jun; 192(6):1788-93; discussion 1793-4. PubMed ID: 15970809
    [Abstract] [Full Text] [Related]

  • 8. A novel 12-hour versus 24-hour magnesium sulfate regimen in the management of eclampsia and preeclampsia in Ghana (MOPEP Study): A randomized controlled trial.
    Beyuo TK, Lawrence ER, Kobernik EK, Oppong SA.
    Int J Gynaecol Obstet; 2022 Nov; 159(2):495-504. PubMed ID: 35304745
    [Abstract] [Full Text] [Related]

  • 9. Interrupted versus continuous magnesium sulfate and blood loss at cesarean delivery.
    Pippen JL, Adesomo AA, Gonzalez-Brown VM, Schneider PD, Rood KM.
    J Matern Fetal Neonatal Med; 2022 Oct; 35(20):3853-3859. PubMed ID: 33179549
    [Abstract] [Full Text] [Related]

  • 10. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial.
    Witlin AG, Friedman SA, Sibai BM.
    Am J Obstet Gynecol; 1997 Mar; 176(3):623-7. PubMed ID: 9077617
    [Abstract] [Full Text] [Related]

  • 11. Favorable hemodynamic effects of magnesium sulfate in preeclampsia.
    Scardo JA, Hogg BB, Newman RB.
    Am J Obstet Gynecol; 1995 Oct; 173(4):1249-53. PubMed ID: 7485331
    [Abstract] [Full Text] [Related]

  • 12. Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium sulfate therapy in severe pre-eclampsia.
    Maia SB, Katz L, Neto CN, Caiado BV, Azevedo AP, Amorim MM.
    Int J Gynaecol Obstet; 2014 Sep; 126(3):260-4. PubMed ID: 24890747
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel protocol for postpartum magnesium sulphate in severe pre-eclampsia: a randomized controlled pilot trial.
    El-Khayat W, Atef A, Abdelatty S, El-Semary A.
    J Matern Fetal Neonatal Med; 2016 Sep; 29(1):154-8. PubMed ID: 25483417
    [Abstract] [Full Text] [Related]

  • 16. Cerebral oximetry assessed by near-infrared spectrometry during preeclampsia: an observational study: impact of magnesium sulfate administration.
    Guerci P, Vial F, Feugeas J, Pop M, Baka NE, Bouaziz H, Losser MR.
    Crit Care Med; 2014 Nov; 42(11):2379-86. PubMed ID: 25072763
    [Abstract] [Full Text] [Related]

  • 17. Shortened postpartum magnesium sulfate treatment vs traditional 24h for severe preeclampsia: a systematic review and meta-analysis of randomized trials.
    Yifu P, Lei Y, Yujin G, Xingwang Z, Shaoming L.
    Hypertens Pregnancy; 2020 May; 39(2):186-195. PubMed ID: 32338165
    [Abstract] [Full Text] [Related]

  • 18. Is there benefit to continue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study.
    Vigil-DeGracia P, Ludmir J, Ng J, Reyes-Tejada O, Nova C, Beltré A, Yuen-Chon V, Collantes J, Turcios E, Lewis R, Cabrera S.
    BJOG; 2018 Sep; 125(10):1304-1311. PubMed ID: 29878650
    [Abstract] [Full Text] [Related]

  • 19. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial.
    Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM.
    Obstet Gynecol; 2003 Feb; 101(2):217-20. PubMed ID: 12576241
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the Level of Magnesium during Maintenance between 2 Gram and 1 Gram per Hour Infusion in Overweight Mothers with Preeclampsia.
    Kitiyodom S.
    J Med Assoc Thai; 2016 Oct; 99 Suppl 7():S133-7. PubMed ID: 29901967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.